Related Experiment Video

Updated: Oct 25, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

2.0K

Challenges in interpreting cytokine data in COVID-19 affect patient care and management

Stephen Y Wang1, Takehiro Takahashi2, Alexander B Pine3,4

  • 1Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.

Plos Biology
|August 6, 2021
PubMed

Insights

Cytokine data challenges hinder Coronavirus Disease 2019 (COVID-19) patient care. This study offers strategies to enhance cytokine data accuracy for better COVID-19 management and research comparisons.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Biomedical Data Science

Background:

  • Cytokine profiling is crucial for understanding disease pathogenesis and patient outcomes.
  • Inconsistent cytokine data complicates the management of Coronavirus Disease 2019 (COVID-19) and hinders cross-study comparisons.
  • The COVID-19 pandemic highlighted significant limitations in the reliable use of cytokine measurements.

Purpose of the Study:

  • To identify and address the challenges associated with utilizing cytokine data in clinical and research settings.
  • To propose actionable mitigation strategies for improving the accuracy and consistency of cytokine measurements.
  • To leverage pandemic-derived experiences for enhancing future cytokine data applications.

Main Methods:

  • Review of existing literature on cytokine measurement and data analysis in the context of viral infections.
  • Analysis of common pitfalls and sources of variability in cytokine data generation and interpretation.
  • Development of a framework for standardized cytokine data collection and quality control.

Main Results:

  • Identified key factors contributing to cytokine data variability, including pre-analytical, analytical, and post-analytical variables.
  • Proposed specific protocols for sample handling, assay selection, and data normalization to improve reliability.
  • Demonstrated the potential impact of standardized methods on enhancing the comparability of cytokine profiles across different studies and patient cohorts.

Conclusions:

  • Standardizing cytokine data acquisition and analysis is essential for accurate Coronavirus Disease 2019 (COVID-19) patient management.
  • Implementing proposed mitigation strategies can significantly improve data quality, enabling more robust comparisons and clinical decision-making.
  • Lessons learned from the COVID-19 pandemic offer a valuable opportunity to refine cytokine data utilization in future infectious disease research.

More Related Videos

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

815
Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform11:00

Multiplex Cytokine Profiling of Stimulated Mouse Splenocytes Using a Cytometric Bead-based Immunoassay Platform

Published on: November 9, 2017

45.5K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.7K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
765
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
63
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
37